Evogene (EVGN) Stock Analysis

Evogene (EVGN) is a publicly traded company in the HEALTHCARE sector. It trades at $0.59, carries a market capitalization of $7.11M. This page summarizes the public market data, fundamentals, and frequently asked questions for EVGN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.59
• Market Cap: $7.11M
• EPS: $-1.70
• 52-Week High: $2.42
• 52-Week Low: $0.65

Market Sentiment

Evogene currently has a Bullish sentiment score of 0.36.

About Evogene

Evogene Ltd. is a pioneering computational biology company based in Rehovot, Israel, specializing in the development of sustainable agricultural solutions through advanced data-driven methodologies. Utilizing its proprietary technology platforms, Evogene focuses on biotechnology applications that enhance crop productivity and resilience, ultimately addressing the challenges of food security in a changing climate. The company's innovative approach leverages genomic data to discover and optimiz...

GNG Research Analysis

GNG Research scores Evogene (EVGN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EVGN.

Frequently Asked Questions

Does EVGN pay dividends?

Evogene (EVGN) does not currently pay a regular dividend.

What is EVGN's market cap?

Evogene (EVGN) has a market capitalization of $7.11M with a current stock price of $0.59.